Table 2 Comparative analysis of clinical data and laboratory test data of children with adenovirus pneumonia in the two groups

Pulse, Mean ± SD

127.66 ± 20.52

123.67 ± 18.59

133.50 ± 21.81

t=-6.21

< 0.001

TP (g/L), Mean ± SD

67.20 ± 6.60

67.47 ± 6.29

66.80 ± 7.03

t = 1.29

0.199

T cell (%), Mean ± SD

61.02 ± 13.06

64.32 ± 11.09

56.19 ± 14.19

t = 8.10

< 0.001

Age (Months), M (Q₁, Q₃)

35.00 (17.00, 59.00)

35.00 (18.00, 56.00)

35.50 (16.00, 64.00)

Z=-0.02

0.982

CRP (mg/L), M (Q₁, Q₃)

8.00 (7.88, 19.07)

8.00 (6.10, 14.43)

11.46 (8.00, 27.23)

Z=-5.81

< 0.001

WBC (10^9/L), M (Q₁, Q₃)

10.82 (7.83, 15.21)

9.36 (7.36, 12.78)

13.18 (9.88, 17.65)

Z=-8.88

< 0.001

LY (%), M (Q₁, Q₃)

35.00 (21.35, 50.55)

43.50 (28.05, 56.25)

25.25 (15.80, 37.02)

Z=-10.78

< 0.001

MONO (%), M (Q₁, Q₃)

8.00 (5.90, 10.50)

8.50 (6.35, 11.00)

7.40 (5.38, 9.62)

Z=-4.66

< 0.001

NEUT (%), M (Q₁, Q₃)

55.20 (37.60, 69.15)

45.80 (32.55, 61.00)

64.00 (53.32, 75.30)

Z=-11.12

< 0.001

LYOE (10^9/L), M (Q₁, Q₃)

3.28 (2.23, 5.04)

3.78 (2.58, 5.36)

2.64 (1.70, 4.32)

Z=-6.63

< 0.001

MONOOE (10^9/L), M (Q₁, Q₃)

0.83 (0.53, 1.25)

0.82 (0.54, 1.23)

0.83 (0.50, 1.25)

Z=-0.05

0.963

RBC (10^12/L), M (Q₁, Q₃)

4.47 (4.21, 4.69)

4.48 (4.25, 4.71)

4.43 (4.14, 4.66)

Z=-2.52

0.012

HGB (g/L), M (Q₁, Q₃)

121.00 (113.50, 127.00)

121.00 (114.00, 127.00)

120.00 (112.00, 127.00)

Z=-1.16

0.245

PT (s), M (Q₁, Q₃)

11.70 (11.00, 12.70)

11.70 (11.10, 12.80)

11.80 (11.00, 12.62)

Z=-1.04

0.297

INR (ratio), M (Q₁, Q₃)

1.04 (0.98, 1.13)

1.05 (0.99, 1.14)

1.04 (0.97, 1.12)

Z=-2.35

0.019

APTT (s), M (Q₁, Q₃)

32.40 (29.20, 36.45)

32.60 (29.94, 36.50)

31.80 (28.58, 36.30)

Z=-2.15

0.032

FIB (g/L), M (Q₁, Q₃)

3.23 (2.68, 3.75)

3.23 (2.73, 3.75)

3.19 (2.65, 3.76)

Z=-0.71

0.480

TT (s), M (Q₁, Q₃)

14.90 (13.80, 16.30)

14.90 (13.90, 16.10)

15.05 (13.70, 16.60)

Z=-0.84

0.401

D-dimer (ng/mL), M (Q₁, Q₃)

300.00 (198.00, 665.00)

222.00 (162.50, 288.00)

801.50 (468.00, 1455.25)

Z=-18.71

< 0.001

FDP (ug/mL), M (Q₁, Q₃)

2.52 (1.25, 4.67)

1.64 (0.99, 2.67)

5.45 (3.11, 9.45)

Z=-16.60

< 0.001

ALT (U/L), M (Q₁, Q₃)

16.00 (12.00, 25.00)

14.00 (11.00, 20.00)

20.50 (13.75, 34.25)

Z=-7.54

< 0.001

AST (U/L), M (Q₁, Q₃)

32.00 (25.00, 45.00)

29.00 (24.00, 37.00)

41.00 (29.00, 63.00)

Z=-8.63

< 0.001

LDH (U/L), M (Q₁, Q₃)

336.00 (270.00, 518.50)

291.00 (252.00, 334.50)

560.00 (426.00, 734.50)

Z=-17.56

< 0.001

CK (U/L), M (Q₁, Q₃)

62.00 (42.00, 91.50)

61.00 (42.00, 82.00)

62.00 (41.00, 113.00)

Z=-2.15

0.032

CKMB (U/L), M (Q₁, Q₃)

26.00 (21.00, 34.00)

23.00 (19.00, 29.00)

31.50 (26.00, 42.00)

Z=-10.65

< 0.001

ALB (g/L), M (Q₁, Q₃)

40.60 (37.70, 43.30)

41.90 (39.60, 44.40)

38.40 (34.50, 41.23)

Z=-11.11

< 0.001

GLB (g/L), M (Q₁, Q₃)

26.50 (23.30, 30.40)

25.50 (22.70, 28.90)

28.00 (24.40, 32.52)

Z=-6.37

< 0.001

AG (ratio), M (Q₁, Q₃)

1.51 (1.29, 1.79)

1.65 (1.43, 1.90)

1.33 (1.13, 1.57)

Z=-10.24

< 0.001

GLU (mmol/L), M (Q₁, Q₃)

4.91 (4.36, 5.68)

4.80 (4.30, 5.46)

5.09 (4.43, 6.06)

Z=-3.52

< 0.001

TBIL (umol/L), M (Q₁, Q₃)

4.50 (3.30, 6.13)

4.50 (3.30, 6.05)

4.50 (3.40, 6.23)

Z=-0.74

0.458

DBIL (umol/L), M (Q₁, Q₃)

2.01 (1.56, 2.71)

2.00 (1.50, 2.60)

2.10 (1.60, 2.90)

Z=-1.51

0.130

IBIL (umol/L), M (Q₁, Q₃)

2.60 (1.61, 3.60)

2.60 (1.70, 3.58)

2.50 (1.60, 3.60)

Z=-0.35

0.729

NK (%), M (Q₁, Q₃)

9.38 (6.00, 15.21)

10.76 (7.05, 16.84)

7.95 (4.87, 12.59)

Z=-6.17

< 0.001

B cell (%), M (Q₁, Q₃)

21.25 (15.14, 29.46)

18.09 (13.83, 23.73)

27.95 (19.72, 39.64)

Z=-10.27

< 0.001

SEX, n (%)

χ²=0.00

0.991

Female

266 (38.05)

158 (38.07)

108 (38.03)

Male

433 (61.95)

257 (61.93)

176 (61.97)

LOS, M (Q₁, Q₃)

7.00 (5.00, 9.00)

6.00 (5.00, 8.00)

9.00 (7.00, 13.00)

Z=-12.55

< 0.001

Underlying disease, n (%)

258 (36.91)

143 (34.46)

115 (40.49)

χ²=2.64

0.104

Co-infection, n (%)

385 (55.08)

196 (47.23)

189 (66.55)

χ²=25.44

< 0.001

Bacteria, n (%)

174 (24.89)

100 (24.10)

74 (26.06)

χ²=0.35

0.556

Virus, n (%)

121 (17.31)

47 (11.33)

74 (26.06)

χ²=25.56

< 0.001

MP, n (%)

197 (28.18)

103 (24.82)

94 (33.10)

χ²=5.71

0.017

FLU, n (%)

40 (5.72)

16 (3.86)

24 (8.45)

χ²=6.60

0.010

RSV, n (%)

34 (4.86)

16 (3.86)

18 (6.34)

χ²=2.25

0.134

EB, n (%)

9 (1.29)

3 (0.72)

6 (2.11)

χ²=1.59

0.208

Respiratory failure, n (%)

33 (4.72)

1 (0.24)

32 (11.27)

χ²=45.58

< 0.001

Heart failure, n (%)

33 (4.72)

1 (0.24)

32 (11.27)

χ²=45.58

< 0.001

Sepsis, n (%)

40 (5.72)

23 (5.54)

17 (5.99)

χ²=0.06

0.804